Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shareholders' Equity: CVSI's Plummeted, CWBHF's Increased
While CVSI's Shares Outstanding increased by 19.1%, its Shareholders' Equity DECREASED 62%.
While CWBHF's Shares Outstanding increased by 4.5%, its Shareholders' Equity INCREASED 57%.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=168255678
Shareholders' Equity: CWBHF's Increased, CVSI's Plummeted
While CWBHF's Shares Outstanding increased by 4.5%, its Shareholders' Equity INCREASED 57%.
While CVSI's Shares Outstanding increased by 19.1%, its Shareholders' Equity DECREASED 38%.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=168255678
CVSI SHAREHOLDER'S EQUITY has PLUMMETED during DILUTION
Between September 30, 2020 and March 09, 2022, CVSI's Outstanding Shares increased from 99.95M to 119.07M, a 19.1% increase.
During that time, CVSI'S SHAREHOLDERS' EQUITY has been SHRUNK MASSIVELY.
FACE FACTS: CVSI's MASSIVE DILUTION
Between September 30, 2020 and March 09, 2022, CVSI's Outstanding Shares increased from 99.95M to 119.07M, a 19.1% increase.
During that time, the CVSI'S SHAREHOLDERS' EQUITY has been SHRINKING MASSIVELY.
Between September 30, 2020 and March 14, 2022, CWBHF's Outstanding Shares increased from 138.87M to 145.07M, a 4.5% increase.
FACE FACTS regarding any DILUTION:
Between September 30, 2020 and March 14, 2022, CWBHF's Outstanding Shares increased from 138.87M to 145.07M, a 4.5% increase.
Between September 30, 2020 and March 09, 2022, CVSI's Outstanding Shares increased from 99.95M to 119.07M, a 19.1% increase.
Comparing Outstanding Shares Increase: CWBHF vs CVSI
Here's what I found:
Between September 30, 2020 and March 14, 2022, CWBHF's Outstanding Shares increased from 138.87M to 145.07M, a 4.5% increase.
Between September 30, 2020 and March 09, 2022, CVSI's Outstanding Shares increased from 99.95M to 119.07M, a 19.1% increase.
BTW "3i" is simply a generic acronym
3i meaning
Don't conflate two distinct "3i"-named businesses!
The large British 3i GROUP (Website: https://www.3i.com)
has ZERO connection with
the small New York 3i Management LLC, (Website: https://3ifund.com/), "the Manager and General Partner of 3i, LP and Tumim Stone Capital", the unfortunate investor in CV Sciences.
Those two distinct investment organizations share only the use of "3i" in their names. To imply otherwise is plainly wrong and misleading.
Face_the_FACTS! CVSciences is Circling the Drain :
A. Multi-year DECLINING 1)REVENUES 2)CASH 3)SHAREHOLDER EQUITY. See Here.
B. Currently, in the context of a multi-year declining CVSI share price, existing CVSI shareholders are being subjected to TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs): 1) The $10M TUMIM DILUTION and 2) The CONVERTIBLE NOTE DILUTION (5 tranches, $5.3M total) with a "FULL RATCHET" provision.
C. Low trading volume with the falling share price effectively has "LOCKED IN" many on this board whose large holdings, if sold, could crater the share price even further. Daily DOLLAR VOLUME is typically under $50K !!! How can large holders sell into THAT??!!
But what about CV Sciences' MANAGEMENT TEAM? They're sure NOT "LOCKED IN".
Two recently-packed "GOLDEN PARACHUTES" (Section 280G of the Internal Revenue Code) are ready for deployment:
1. June 23, 2021
Here's WHAT was SAID and BY WHOM :
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168262467
Business Performance: CVSciences vs Charlotte'sWeb
Since its IPO in August 2018, Charlotte's Web's REVENUES HAVE GROWN MUCH HIGHER than CV Sciences' and its SHAREHOLDERS' EQUITY HAS NEARLY TRIPLED, while CV Sciences' has fallen precipitously.
CV Sciences' 2021 Q3 Report
Charlotte's Web's 2021 Q3 Report
From 12/31/2019 through 09/30/21 :
CV Sciences' SHAREHOLDERS' EQUITY DECREASED from $29.1M to $11.1M.
Charlotte's Web's SHAREHOLDERS' EQUITY INCREASED from $153.7M to $241.7M.
COMPARING REVENUES AND CASH:
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
Don't get too excited. LOL.
With numbers like today's:
CVSI is good for a day trade but virtually impossible for the hard-luck big-bagholders here to cash out without tanking the shareprice. They're stuck.
Some, in spite of CV Sciences' deteriorated fundamentals, even add to their "bags" . . . or so they claim.
"TINY"?! CVSciences offers ~HALF its CASH !
CV SCIENCES, INC. SECURITIES LITIGATION :
Come to think of it: CV Sciences' cash position IS "TINY". LOL.
CV Sciences' CASH BURN: Ina Settlement
CV SCIENCES, INC. SECURITIES LITIGATION :
CV Sciences' OUTSOURCING:
Wolf-man jack asserted:
Topicals in Kroger is VERY OLD(2019)News
Press Releases from 2019:
Charlotte's Web:
https://investors.charlottesweb.com/press-releases/press-release-details/2019/Charlottes-Web-Hemp-CBD-Topical-Products-Expanding-to-1350-Kroger-Stores-Across-22-States/default.aspx
CV Sciences:
https://ir.cvsciences.com/press-releases/detail/115/cv-sciences-inc-announces-new-distribution-with-kroger
CV Sciences' Legacy of Corporate Fraud
The class action lawsuit (Lead Plaintiff Richard Ina) is just a recent action against CV Sciences and its officers for VIOLATION OF FEDERAL SECURITIES LAWS. The following is an excerpt from the proposed settlement, In re: CV SCIENCES, INC. SECURITIES LITIGATION, agreed to by all parties and filed 01/31/2022:
But the STENCH OF CORPORATE FRAUD lasts a LONG TIME:
1. Recall the March 2020 SEC document referenced in earlier posts regarding Cannvest aka "CV Sciences".
2. Here's the full June 16, 2017 SEC release
Here's a link to the 19 page-long June 15, 2017 SEC Complaint referenced in that SEC Press Release:
https://www.sec.gov/litigation/complaints/2017/comp23861.pdf
Business Performance: CV_Sciences vs Charlotte's_Web
Since its IPO in August 2018, Charlotte's Web's REVENUES have grown much higher than CV Sciences' and Charlotte's Web's SHAREHOLDERS' EQUITY has nearly tripled, while CV Sciences' has fallen precipitously.
See the following recent data:
CV Sciences' 2021 Q3 Report
Charlotte's Web's 2021 Q3 Report
From 12/31/2019 through 09/30/21 :
CV Sciences' SHAREHOLDERS' EQUITY DECREASED from $29.1M to $11.1M.
Charlotte's Web's SHAREHOLDERS' EQUITY INCREASED from $153.7M to $241.7M.
COMPARING REVENUES AND CASH:
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
Plaintiff, Ina, recognizes CVSciences' shaky financial position
CV SCIENCES, INC. SECURITIES LITIGATION :
CV Sciences is "Circling the Drain" :
A. Multi-year DECLINING 1)REVENUES 2)CASH 3)SHAREHOLDER EQUITY. See Here.
B. Currently, in the context of a multi-year declining CVSI share price, existing CVSI shareholders are being subjected to TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs): 1) The $10M TUMIM DILUTION and 2) The CONVERTIBLE NOTE DILUTION (5 tranches, $5.3M total) with a "FULL RATCHET" provision.
C. Low trading volume with the falling share price effectively has "LOCKED IN" many on this board whose large holdings, if sold, could crater the share price even further. Daily DOLLAR VOLUME is typically under $50K !!! How can large holders sell into THAT??!!
But what about CV Sciences' MANAGEMENT TEAM? They're sure NOT "LOCKED IN".
Two recently-packed "GOLDEN PARACHUTES" (Section 280G of the Internal Revenue Code) are ready for deployment:
1. June 23, 2021
CVSI HAS BEEN ON_A_DECLINE FOR YEARS:
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
NFL Honoring Maroon ? Hmmm.
See FRONTLINE Interview: League of Denial: The NFL's Concussion Crisis regarding Maroon's role.
Contrast Maroon's activities with the work of Dr. Bennet Omalu, honored by the American Medical Association -- that's "AMA" not "NFL". Dr. Omalu "overcame massive efforts to discredit him and his research" on Chronic traumatic encephalopathy (CTE).
CWBHF vs CVSI:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
February 28, 2022:
Share Price: $1.18 (0.11 times the December 2018 value)
COMPARE TO
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
February 28, 2022:
Share Price: <$0.12 (<0.03 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is CONSISTENT with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
LA Weekly? Reviewing SanDiego-based CV Sciences?
https://mediabiasfactcheck.com/la-weekly/
CVSI vs CWBHF:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
February 28, 2022:
Share Price: <$0.12 (<0.03 times the December 2018 value)
COMPARE TO
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
February 28, 2022:
Share Price: $1.18 (0.11 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is CONSISTENT with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
No. Not merely "the plaintiff's response"
CV SCIENCES, INC. SECURITIES LITIGATION :
So sorry. LOL ;)
Ina: Take the cash NOW!! LOL
CV SCIENCES, INC. SECURITIES LITIGATION
REALITY: CV Sciences shareholder DILUTION NOW:
https://www.marketwatch.com/investing/stock/cvsi/financials/income/quarter
NOTE the approximate 10% increase in shares outstanding during just the first 3 quarters of 2021.
RECALL that in the 4th quarter of 2021 CV Sciences had TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs) in effect which, no doubt, will further increase shares outstanding by the end of 2021. And one remains in effect in 2022.
Contrast with Charlotte's Web:
https://www.marketwatch.com/investing/stock/cwbhf/financials/income/quarter